Finance
Goldman Sachs Says ‘Go for Gold’ as Prices Shine Amid Uncertainty
Gold Prices Surge Amid Global Tensions – Gold investors should “go for gold,” according to analysts at Goldman Sachs. They predict that gold prices will...
Justice Department Intensifies Antitrust Investigation of Nvidia
Nvidia Antitrust Investigations Intensify –Â The U.S. Justice Department (DOJ) has escalated its investigation into Nvidia Corp. by issuing subpoenas to the chipmaker and other...
US Stocks Take a Hit as September Begins
Tech Stocks Lead the Decline –Â US stocks fell sharply on Tuesday, marking the start of September, a month known for its historical challenges in...
Costco Increases Membership Fees for the First Time in Six Years
Costco’s Membership Fees Rise: What It Means for Shoppers and the Retail Giant -Costco Wholesale Corporation (COST) has announced an increase in its annual membership...
Recursion Pharmaceuticals Plunges 15% After Mixed Phase 2 Trial Results for CCM Treatment
Recursion Pharmaceuticals Faces Market Backlash After Phase 2 Trial Results Update Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell sharply on Tuesday, after the company released...
Liberty Latin America Faces Mixed Institutional Moves Amid Changing Stock Ratings
Institutional Investors Adjust Liberty Latin America Holdings Ingalls & Snyder LLC reduced its stake in Liberty Latin America Ltd. (NASDAQ: LILA) by 42.1% in the...
Iris Energy Defies Doubts with Record Revenue and Aggressive Expansion Plans
Iris Energy Overcomes Doubts with Record Revenue Iris Energy (IREN) recently posted record revenue despite facing a 50% share slump. This drop followed skepticism from...
IO Biotech: Clinical Trials Progress: Analysts Adjust Ratings Amid New Data
Jefferies Lowers Price Target for IO Biotech Jefferies has maintained its “Buy” rating for IO Biotech (NASDAQ: IOBT) but has reduced its price target from...
Dyne Therapeutics Strengthens Leadership Team Amid Strategic Shift to Drive Growth
Dyne Therapeutics Announces Key Leadership Changes Dyne Therapeutics (Nasdaq: DYN), a clinical-stage company specializing in muscle disease therapeutics, has unveiled significant leadership appointments to bolster...
US Stocks Slide as Markets Brace for Key Jobs Report and Political Uncertainty
US Stocks Begin September on a Down Note US stocks fell on Tuesday, marking a weak start to a traditionally challenging month for markets. The...
